Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

Yan Jiang,1,* Zhen-Lin Zhang,2,* Zhong-Lan Zhang,3 Han-Min Zhu,4 Yi-Yong Wu,5 Qun Cheng,4 Feng-Li Wu,5 Xiao-Ping Xing,1 Jian-Li Liu,3 Wei Yu,6 Xun-Wu Meng11Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijin...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiang Y, Zhang ZL, Zhu HM, Wu YY, Cheng Q, Wu FL, Xing XP, Liu JL, Yu W, Meng XW
Format: article
Language:EN
Published: Dove Medical Press 2014
Subjects:
menatetrenone
alfacalcidol
postmenopausal
osteoporosis
mineral bone density
undercarboxylated osteocalcin
Geriatrics
RC952-954.6
Online Access:https://doaj.org/article/1914110c98d9478986cdcba2c6582d5c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/1914110c98d9478986cdcba2c6582d5c

Similar Items